Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,787 public trials 1,782 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Active, not recruiting

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

NCT05563220

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Dothan Hematology and Oncology Dothan, Alabama, United States
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • City of Hope National Medical Center Duarte, California, United States
View all 83 locations
View Trial Details
Active, not recruiting

A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer

NCT05852691

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Cancer Blood and Specialty Clinic Los Alamitos, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Novant Health Presbyterain Medical Center Charlotte, North Carolina, United States
  • Avera Cancer Institute Sioux Falls, South Dakota, United States
View all 36 locations
View Trial Details
Active, not recruiting

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer

NCT04544189

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Novartis Investigative Site Hefei, Anhui, China
  • Novartis Investigative Site Hefei, Anhui, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Shijiazhuang, Hebei, China
View all 24 locations
View Trial Details
Active, not recruiting

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

NCT00099437

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Research Site Casa Grande, Arizona, United States
  • Research Site Fountain Valley, California, United States
  • Research Site New Britain, Connecticut, United States
  • Research Site Crystal River, Florida, United States
View all 106 locations
View Trial Details

Related conditions